Does WellMedr or Ro Body offer microdosing?

WellMedr explicitly offers a microdosing protocol, allowing patients to start at 1.25mg tirzepatide/week — half the standard dose. Ro Body follows a standard FDA escalation schedule and does not offer a formalised sub-dose titration option.

Which platform is better for semaglutide (Ozempic/Wegovy)?

Ro Body has historically focused on semaglutide and offers both compounded and branded options (Wegovy). WellMedr focuses primarily on tirzepatide (Zepbound/Mounjaro). If you specifically want semaglutide, Ro Body is the stronger platform.

How fast can I get started — WellMedr or Ro Body?

WellMedr offers same-day consultations in most cases. Ro Body's consultation process typically takes 24–48 hours before a prescription is issued. Both ship within 3–5 business days once the prescription is active.

Are WellMedr and Ro Body both US-only?

Yes. Both platforms are US-only, require a US-licensed physician consultation, and ship exclusively within the United States. Neither service is available internationally.

Home/Compare/WellMedr vs Ro Body

COMPARISON · GLP-1 TELEHEALTHUpdated May 2026

WellMedr vs Ro Body (2026): GLP-1 Telehealth Compared

Q: Is WellMedr cheaper than Ro Body?

Yes. WellMedr starts at $88/month for compounded tirzepatide, while Ro Body's compounded semaglutide starts around $99/month and their branded GLP-1 programmes run $145–$299+/month depending on the plan. WellMedr's lower price point reflects its use of compounded tirzepatide rather than branded pens.

Q: Which is better for first-time GLP-1 users?

WellMedr's microdosing option makes it a better choice for GLP-1 beginners who are concerned about side effects. Ro Body's more established brand and semaglutide experience makes it a solid choice for patients who have been recommended Ozempic or Wegovy specifically.

Both platforms offer compounded GLP-1 medications for weight loss. WellMedr leads on price, microdosing, and tirzepatide outcomes. Ro Body wins on medication variety and branded drug access. We ran both through our FSP scoring framework to find out which delivers better value for different patient profiles.

FSP Score

8.0/10

WellMedr

5 categories won

FSP Score

7.2/10

Ro Body

2 categories won

Affiliate disclosure: WellMedr links on this page are affiliate links — Fitlabreviews may earn a commission if you purchase. Ro Body is not affiliated. Scores are editorially independent. Policy → · Medical disclaimer →

Our Verdict

WellMedr wins overallfor most patients starting GLP-1 therapy in 2026. Its microdosing option, lower price point ($88/mo), and tirzepatide's superior weight-loss evidence (20.9% mean reduction vs 14.9% for semaglutide) give it a clear edge for first-time users and GI-sensitive patients.

Ro Body is the better choice if you specifically need semaglutide (Ozempic/Wegovy), want access to branded prescriptions, or have insurance that covers semaglutide-specific medications.

§ 01Side-by-Side

Full Feature Comparison

Category	WellMedr	Ro Body	Winner
Starting Price	From $88/mo	From $99/mo	WellMedr
Medication Options	Compounded Tirzepatide	Compounded Sema + Branded GLP-1s	Ro Body
Microdosing Available	Yes — 1.25mg start	No formal protocol	WellMedr
Consultation Speed	Same-day (most cases)	24–48 hours typical	WellMedr
Check-in Model	Monthly async + chat	Monthly async + app	TIE
Branded Meds Option	No	Yes (Wegovy, Ozempic)	Ro Body
Side-Effect Support	Microdosing + physician consult	Standard clinical support	WellMedr
TrustPilot Rating	4.0★ (300+ reviews)	3.9★ (1,200+ reviews)	TIE
Weight Loss Evidence	Tirzepatide: 20.9% avg	Semaglutide: 14.9% avg	WellMedr
US Only	Yes	Yes	TIE

Scores based on Fitlab Scoring Protocol (FSP) v2.1. Pricing accurate as of May 2026; may change. Check providers directly for current plans.

§ 02Pricing

Cost Breakdown & Value

WellMedr

Compounded Tirzepatide

From $88/mo

1.25–15mg/week; monthly supply

Consultation

Included

Same-day async consultation

Ongoing Check-ins

Included

Monthly + chat support

Ro Body

Compounded Semaglutide

From $99/mo

0.25–2.4mg/week

Branded Wegovy

$299+/mo (after ins.)

Subject to insurance; varies widely

Ro Body Programme

$145/mo

Full programme: coaching + meds

WellMedr's $88/month entry point is the lowest of any major GLP-1 telehealth platform we reviewed. The savings are possible because WellMedr exclusively uses compounded tirzepatide — the branded equivalent (Zepbound) costs $550–650/month without insurance. Neither platform charges a consultation fee or membership separately.

§ 03Medications

Tirzepatide vs Semaglutide

The core medication difference: WellMedr uses tirzepatide (dual GIP/GLP-1 agonist); Ro Body primarily uses semaglutide (GLP-1 agonist only). This is not a minor detail — head-to-head data now shows meaningfully different outcomes.

SURMOUNT-5 Head-to-Head Trial (Jastreboff 2024)

Weight Loss (72 wk)

Tirzepatide: 20.2%

Semaglutide: 13.7%

≥20% Body Weight Loss

Tirzepatide: 31.6%

Semaglutide: 16.1%

GI Adverse Events

Tirzepatide: Comparable

Semaglutide: Comparable

Tirzepatide's advantage comes from its dual mechanism — GIP receptor agonism adds appetite suppression and fat metabolism effects on top of GLP-1's satiety signalling. If your primary goal is maximum weight loss, the evidence favours tirzepatide (WellMedr) over semaglutide (Ro Body).

§ 04Recommendation

Which Platform Is Right for You?

Choose WellMedr if...

You want the lowest price ($88/mo)
You're new to GLP-1s and worried about side effects (microdosing available)
You want the strongest weight-loss evidence (tirzepatide over semaglutide)
You want same-day access — consult within hours
You have no insurance coverage for branded GLP-1s

Choose Ro Body if...

You specifically need semaglutide (physician-recommended Ozempic/Wegovy)
You have insurance that covers branded GLP-1 medications
You want a larger existing review base and longer-established platform
You prefer a structured coaching programme alongside medication

§ 05Get Started

Start Your GLP-1 Journey

WellMedr

OUR TOP PICK

Compounded tirzepatide from $88/mo. Microdosing available. Same-day consultations. US residents only.

Start at WellMedr ↗Read Full Review →

Ro Body

Compounded semaglutide from $99/mo. Branded Wegovy/Ozempic options. Insurance assistance available. US only.

Ro Body is not an affiliate partner. We link editorially only. Visit robody.com directly.

§ 06FAQ

Frequently Asked Questions

Is WellMedr cheaper than Ro Body?

Yes. WellMedr starts at $88/month vs Ro Body's $99/month entry. Ro Body's branded programme runs $145–$299+/month.

Does WellMedr offer microdosing?

Yes — WellMedr allows starting at 1.25mg tirzepatide/week (half the standard dose) with extended 6–8 week escalation windows. Ro Body does not offer a formalised microdosing protocol.

Which is better for semaglutide users?

Ro Body. It offers compounded and branded semaglutide (Wegovy/Ozempic). WellMedr focuses exclusively on tirzepatide.

How fast is the consultation process?

WellMedr offers same-day consultations in most cases. Ro Body typically takes 24–48 hours before a prescription is issued.

Are both platforms US-only?

Yes. Both WellMedr and Ro Body are US-only services requiring a US-licensed physician and shipping within the United States only.

Which is better for first-time GLP-1 users?

WellMedr, primarily because of its microdosing option — it significantly reduces the chance of GI side effects that cause first-time users to discontinue therapy prematurely.

§ 07References

Sources & Citations

Jastreboff AM, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine, 387(3), 205–216.
Jastreboff AM, et al. (2024). Tirzepatide vs. Semaglutide for Obesity (SURMOUNT-5). New England Journal of Medicine, 391(2), 109–119.
Wilding JPH, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). New England Journal of Medicine, 384(11), 989–1002.
Aronne LJ, et al. (2024). Continued Treatment with Tirzepatide for Maintenance of Weight Reduction (SURMOUNT-4). New England Journal of Medicine, 390(8), 730–740.
FDA. (2023). Zepbound (tirzepatide) injection prescribing information.
FDA. (2021). Wegovy (semaglutide) injection prescribing information.

WellMedr Review (2026) — GLP-1 Telehealth Rated 8/10 →Tirzepatide: Mechanism, Benefits & Side Effects →Microdose GLP-1 Telehealth: Does It Work? →